Alten: Q1 13 sales below expectations, initial FY13 guidance invalidated

NEUTRAL vs. BUY, Fair Value EUR30 vs. EUR37 (-2%)

News published on April Tuesday 30, 2013
Share on

We downgrade Alten to Neutral from Buy, and cut our DCF-derived fair value to EUR30 from EUR37, with a 13-15% reduction in our adj. EPS forecasts (-EUR4) and a higher beta (1.8 vs. 1.6, -EUR3) in order to reflect the less favourable sales and profit momentum. Q1 13 sales were disappointing and initial FY13 guidance (sales up at least 4%, op. margin at 10%+) is invalidated due to a clear lengthening in decision cycles. We deem the share price will react negatively near-term, but at this stage Alten looks to be well armed for keeping utilisation rates and prices at decent levels.

Full report available to subscribers
Please contact 

The Essentials

Everything you need to know about investment banking dedicated to growth
Recent Transactions Highlights
From M&A, to IPOs see what’s been happening at Bryan, Garnier & Co this year
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities